RSV Alert - Respiratory Syncytial Virus Antigen Test - SA Scientific (30 Per Box)
- Ships same day if by 3pm EST. Signature required delivery.
- Calculated at Checkout
Respiratory Syncytial Virus RSV Alert Antigen Test - SA Scientific (30 Per Box)
A Rapid Visual Assay for the Qualitative Detection of Respiratory Syncytial Virus Antigen in Nasopharyngeal Specimens
SAS™ RSVAlertAlert antigen test kit is a visual and rapid assay for the qualitative detection of Respiratory Syncytial Virus (RSV) antigen directly from nasopharyngeal specimens in neonatal and pediatric patients. The test is for in-vitro diagnostic use only. It is recommended that negative test results be confirmed by cell culture.
The current expiration date for this RSV test is on or better than: MAY 31, 2024
Ships same business day if by 3pm EST. SIGNATURE required delivery.
Test Insert Literature:
Introduction: Respiratory Syncytial Virus (RSV) is a common respiratory virus that primarily affects infants and young children, although it can also affect adults, particularly the elderly or those with compromised immune systems. While most RSV infections are mild and manifest as cold-like symptoms, in certain cases, it can lead to serious respiratory illnesses such as bronchiolitis or pneumonia.
RSV is the most common cause of bronchiolitis and pneumonia in children under one year of age.
Almost all children will have been infected with RSV by their second birthday.
RSV infections typically occur during fall, winter, and spring. The exact timing and duration of RSV seasons can vary by geographic regions.
RSV spreads through respiratory droplets, either by direct contact with an infected person or by touching a surface or object contaminated with the virus. The virus can live for several hours on hard surfaces.
Mild symptoms might include a runny nose, decrease in appetite, coughing, sneezing, fever, and wheezing.
Severe symptoms can involve high fever, severe cough, wheezing, rapid or difficult breathing, bluish skin (from lack of oxygen), and respiratory failure.
Populations at Risk:
While anyone can contract RSV, certain groups are at higher risk for severe disease:
Infants, especially those born prematurely
Children with heart or lung diseases
People with compromised immune systems
Diagnosis: RSV can be diagnosed by a healthcare provider based on the patient’s clinical symptoms and laboratory tests on nasal or throat swabs.
Most cases of RSV are mild and can be managed at home. Treatment mainly involves symptom relief: hydration, fever reduction, and nasal suctioning for infants.
Hospitalization might be required for severe cases, especially for those experiencing dehydration or difficulty breathing. In hospital settings, oxygen and intravenous fluids might be administered.
There's no specific antiviral treatment routinely recommended for RSV infections. Some high-risk patients might benefit from the antiviral medication ribavirin, but its use is limited due to potential side effects.
Hand hygiene: Regularly washing hands with soap and water for at least 20 seconds can reduce the spread of RSV.
Avoid close contact: Limiting exposure to sick individuals can reduce the risk of infection.
Clean surfaces: Regularly disinfect surfaces and objects that children come in contact with.
Limit exposure for infants: During RSV season, it's beneficial to reduce an infant's exposure to crowded places.
A medication called palivizumab can be given to certain high-risk children in monthly injections during RSV season to prevent severe RSV illness.
Conclusion: RSV is a significant health concern, especially for young children and the elderly. Awareness of the symptoms, risk factors, and preventive measures can help reduce the spread and impact of this common respiratory virus.